Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.606 SEK | -5.31% | -8.46% | -50.73% |
Apr. 16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
Mar. 08 | Transcript : Nanexa AB - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.73% | 7.5M | |
-10.84% | 187M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa Signs Feasibility Study Contract for PharmaShell; Shares Jump